Li D, Darden C, Osman N, Sayeed S, Jackson L, Garbinsky D, Chauhan A. Real-world clinical and patient-reported outcomes from the longitudinal telotristat ethyl treatment registry of patients with neuroendocrine tumors. Cancer Manag Res. 2022 Oct 17;14:3009-20. doi: 10.2147/CMAR.S386419
Hofheinz RD, Bruix J, Demetri GD, Grothey A, Marian M, Bartsch J, Odom D. Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types. Cancer Manag Res. 2021 Jul 12;13:5523-33. doi: 10.2147/CMAR.S305939
Park EM, Check DK, Yopp JM, Deal AM, Edwards TP, Rosenstein DL. An exploratory study of end-of-life prognostic communication needs as reported by widowed fathers due to cancer. Psychooncology. 2015 Nov;24(11):1471-6. doi: 10.1002/pon.3757
Cuyún Carter G, Barrett AM, Kaye JA, Liepa AM, Winfree KB, John WJ. A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer. Cancer Manag Res. 2014 Oct 23;2014(6):437-49. doi: 10.2147/CMAR.S63603
Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013 Apr;22(4):745-55. doi: 10.1002/pon.3055
Sharp L, Cotton S, Carsin AE, Gray N, Thornton A, Cruickshank M, Little J, TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the trial of management of borderline and other low-grade abnormal smears (TOMBOLA). Psychooncology. 2013 Feb;22(2):368-80. doi: 10.1002/pon.2097
Adams, Jr SG, Britt (DiBenedetti) DM, Godding PR, Khansur TI, Bulcourf BB. Relative contribution of the Karnofsky Performance Status Scale in a multi-measure assessment of quality of life in cancer patients. Psychooncology. 1995 Oct;4(3):239-46. doi: 10.1002/pon.2960040310